Miyagi, Japan

Chi Long Nguyen

This inventor holds 1 USPTO granted patent. Top assignee: Tohoku University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi Long Nguyen. Retrieved from https://idiyas.com/inventor/chi-long-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chi Long Nguyen: Innovator in Hematopoiesis Research

Introduction

Chi Long Nguyen is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of hematopoiesis, particularly in developing treatments for anemia. His innovative work has the potential to impact many lives by addressing a critical health issue.

Latest Patents

Chi Long Nguyen holds a patent for a hematopoiesis-enhancing agent. The purpose of this invention is to provide a novel hematopoiesis-promoting agent and a medicament that comprises this agent as an active ingredient for preventing or treating anemia, especially refractory anemia. The invention specifically includes a hematopoiesis-promoting agent that comprises an S-adenosylmethionine synthase inhibitor. This patent represents a significant advancement in the treatment of anemia.

Career Highlights

Chi Long Nguyen is affiliated with Tohoku University, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Chi Long Nguyen has worked alongside notable colleagues such as Kazuhiko Igarashi and Hiroki Kato. Their collaborative efforts have furthered the research in hematopoiesis and related medical fields.

Conclusion

Chi Long Nguyen's innovative work in developing a hematopoiesis-enhancing agent showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for individuals suffering from anemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…